Trial NCT04639843

View at ClinicalTrials.gov 
Org. Study IDs: 200169
Secondary IDs: 20-C-0169

Last trial update was posted on 2022-11-04

MeSH Interventions

Azacitidine Cc-486 Doxorubicin Romidepsin

MeSH Conditions

Enteropathy-Associated T-Cell Lymphoma Leukemia, T-Cell Leukemia-Lymphoma, Adult T-Cell Lymphoma Lymphoma, Extranodal NK-T-Cell Lymphoma, T-Cell Lymphoma, T-Cell, Peripheral

Other Conditions

Adult T-cell Leukemia/Lymphoma Extranodal NK-/T-cell Lymphoma, Nasal Type Hepatosplenic T-cell Lymphoma Monomorphic Epiteliotrophic Intestinal T-cell Lymphoma

Stopping Reasons

Safety issues with PI3 kinase inhibitors

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID